Construction of TME signatures and functional annotation.

Slides:



Advertisements
Similar presentations
Homozygous deletions within chromosome 9q23.
Advertisements

Expression analyses of KLK7 mRNA in the brains of AD patients
The immune metagene model has prognostic value in IBE but not in IBD breast cancer. The immune metagene model has prognostic value in IBE but not in IBD.
Frequency of JAK1 and JAK2 alterations and their association with overall survival in TCGA datasets. Frequency of JAK1 and JAK2 alterations and their association.
A: Box plot comparing the average changes in HbA1c between surgery and medical/lifestyle treatments in the first reports of the 11 RCTs published to date.
Host transcriptional profiling distinguishes patients with acute LRTI (LRTI+C+M) from those with noninfectious acute respiratory illness (no-LRTI). Host.
Nonclassical monocytes are specifically depleted following M-CSFR inhibition and these cells are highest in PD-L1 expression in blood of mice during therapy.
Somatic promoters correlate with immunoediting signatures.
Differences in the glycated hemoglobin (HbA1c) levels.
Graph (box plots) shows primary tumor volumes of oral and maxillary sinus (A) and pharyngeal (B) cancers categorized at T1–T4. Graph (box plots) shows.
Tumor development of poorly immunogenic LLC and B16F10 cells modified to produce GM-CSF was markedly inhibited. Tumor development of poorly immunogenic.
B7-H4 expression correlates with MHC-I expression and improved prognosis in patients with breast cancer. B7-H4 expression correlates with MHC-I expression.
Volume 4, Issue 3, Pages (August 2013)
Kaplan–Meier survival curves of all-cause mortality in patients with idiopathic pulmonary fibrosis (IPF). Kaplan–Meier survival curves of all-cause mortality.
A and B, ROC curves of the proteomics panel diagnosis.
Box-And-Whisker Plots
Microenvironmental immune cell signatures dictate clinical outcomes for PTCL-NOS by Takeshi Sugio, Kohta Miyawaki, Koji Kato, Kensuke Sasaki, Kyohei Yamada,
Simon W. Rabkin et al. JACEP 2017;3:
Robustness of TRU, Proximal-proliferative (PP), and Proximal-inflammatory (PI) classification. Robustness of TRU, Proximal-proliferative (PP), and Proximal-inflammatory.
Volume 26, Issue 12, Pages e5 (March 2019)
Thermomorphogenesis in seedling organs is autonomous or interdependent
Box plot of acquisition times across the various study cohorts.
Transcription/abundance ratios (logarithmic scale) of OTUs, ZOTUs, and population genomes of selected microbial orders. Transcription/abundance ratios.
Survival based on V gene mutation status and CD38 expression among B-CLL patients who stratify to the Rai intermediate risk category. Survival based on.
Distinct molecular and clinical correlates of H3F3A mutation subgroups
Derivation of ImSig. Derivation of ImSig. A, An example of a correlation network generated from a tissue data set where nodes represent unique genes and.
Association between RB pathway alterations and poor prognosis in early-stage lung adenocarcinoma patients. Association between RB pathway alterations and.
Integrated mRNA and microRNA expression and DNA methylation clusters.
Progastrin expression in colonic tissues and Kaplan–Meier survival curves. Progastrin expression in colonic tissues and Kaplan–Meier survival curves. A,
PD-L1 expression correlates with T-cell markers and an IFN response signature in human melanomas. PD-L1 expression correlates with T-cell markers and an.
Landscape of the TME in gastric cancer and characteristics of TME subtypes. Landscape of the TME in gastric cancer and characteristics of TME subtypes.
Antitumor activity of KM100+5 μmol/L MTX treatment in the presence or absence of CD8+ T cells in BALB-neuT mice bearing subcutaneous tumors of TUBO cells.
A, Overall survival of patients treated with CAR T cells (black line; n = 15). A, Overall survival of patients treated with CAR T cells (black line; n.
CXCL14-positive CAFs induce overexpression of LINC00092 in ovarian cancer. CXCL14-positive CAFs induce overexpression of LINC00092 in ovarian cancer. A,
Immune signatures of patients with short-, medium-, and long-term survival. Immune signatures of patients with short-, medium-, and long-term survival.
CD8, galectin-3, galectin-9, and the M1/M2 ratio are associated with a longer survival. CD8, galectin-3, galectin-9, and the M1/M2 ratio are associated.
M-Wnt and E-Wnt cells cluster tightly with claudin-low and basal-like breast tumors, respectively, by microarray analysis. M-Wnt and E-Wnt cells cluster.
Melanoma patient monocytes have altered expression of inflammatory and surface markers. Melanoma patient monocytes have altered expression of inflammatory.
EN1 expression in breast cancer and clinical outcome.
Somatic mutational rates and survival analysis of IBD-CRC.
IL1R8 is downmodulated in human lymphoma cell lines.
Survival risk prediction analysis and application of the metastasis gene signature. Survival risk prediction analysis and application of the metastasis.
Coexpression of other immune genes with ImSig core signatures.
PD-1 expression in ovarian cancer.
Scatter and box plot of midpoint measurement compared with age of subject. Scatter and box plot of midpoint measurement compared with age of subject. The.
The long tail of mutational hotspots in cancer.
Association of overall survival and PAP-specific (A, B) and PA2024-specific (C, D) CTL activity at week 26 using categorical (tertile) analysis and continuous.
Increased frequency and number of KLL-specific clonotypes in tumors is associated with improved MCC-specific survival. Increased frequency and number of.
Frequently mutated genes in colorectal cancer.
Inhibition of CD20 mRNA expression by ibrutinib correlates with reduced NF-κB activity. Inhibition of CD20 mRNA expression by ibrutinib correlates with.
One-year costs by evaluation strategy.
Progression and survival analysis.
Volume 28, Issue 3, Pages e7 (July 2019)
In situ expression of signature genes in the Th1, Th2, Th17, and Treg pathways. In situ expression of signature genes in the Th1, Th2, Th17, and Treg pathways.
MYC and LYN are coexpressed and have interdependent clinical outcomes.
Gene expression heatmap of non–T-cell-inflamed, intermediate, and T-cell–inflamed testicular germ cell tumors from TCGA. Genes are on the row, and samples.
Expression of TGFβ ligands in GBM
TMEscore is a prognostic biomarker and predicts immunotherapeutic benefit. TMEscore is a prognostic biomarker and predicts immunotherapeutic benefit. A,
Subtype classification of breast functional screening results.
Cell counts of immune infiltrate and expression of galectin-1 and galectin-3 in the short-, medium-, and long-term survival cohorts. Cell counts of immune.
Identification and characterization of activated integrin pathway module by signal transduction representation (A) and unsupervised hierarchical clustering.
Highly metastatic PDAC cells have a unique gene signature, which is not preserved in metastases but predicts poor patient outcome. Highly metastatic PDAC.
Transcriptome traits and clinical characteristics of TME phenotypes in the ACRG cohort. Transcriptome traits and clinical characteristics of TME phenotypes.
TME characteristics of TCGA-STAD subtype and cancer somatic genome.
Synthetic lethality of ROS1 inhibition in E-cadherin–deficient breast tumor cell lines. Synthetic lethality of ROS1 inhibition in E-cadherin–deficient.
Coincidence and prognostic significance of PD-1+ and CD103+ cells in HGSC. Serial sections from the 490-case TMA were stained with antibodies to CD103.
Isolation of large soft agar clones from HBEC3p53,KRAS and HBEC3p53,KRAS,MYC identifies tumorigenic and nontumorigenic clones and genome-wide mRNA expression.
Kaplan–Meier curves of relapse-free survival of the CAR-T cohort (left) and the HCT cohort (right) of 8 CAR-T patients and 12 HCT patients whose preceding.
Intersubject distribution of eGFR slope (left) and mGFR slope (right).
GSN and DNMT1 expression are inversely correlated in a pattern associated with patient survival. GSN and DNMT1 expression are inversely correlated in a.
Presentation transcript:

Construction of TME signatures and functional annotation. Construction of TME signatures and functional annotation. A, Unsupervised analysis and hierarchical clustering of common DEGs based on expression data derived from the ACRG cohort to classify patients into three groups: Gene clusters A–C. Immuno-group (immunophenotype from previous study; ref. 7), survival status, ACRG subtype, MSI status, histologic subtype, and TMEcluster are shown as patient annotations. B, Kaplan–Meier curves for the three groups of patients. Gene cluster A (n = 64), B (n = 158), and C (n = 77). Log-rank test showed an overall P < 0.001. C and D, GO enrichment analysis of the two TME relevant signature genes—TME signature gene (C) A and (D) B. The x axis indicates the number of genes within each GO term. E, The fraction of TME cells in three gene clusters. Within each group, the scattered dots represent TME cell expression values. We also plotted the Immunoscore of three gene clusters. The thick line represents the median value. The bottom and top of the boxes are the 25th and 75th percentiles (interquartile range). The whiskers encompass 1.5 times the interquartile range. The statistical difference of three gene clusters was compared through the Kruskal–Wallis test. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001. Dongqiang Zeng et al. Cancer Immunol Res 2019;7:737-750 ©2019 by American Association for Cancer Research